• BX Home
  • Allergan Inc.: News [Page 2]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ALLERGAN INC.

Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.

Allergan Inc. is part of Business Exchange, suggested by Ulli Muenker. This topic contains 244 news and 82 blog items. Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from like-minded professionals.

News

Please add new articles to this topic

Allergan���s Wrinkle-Busting Botox to Grow From Therapeutic Usesmore

May 9 (Bloomberg) -- Allergan Inc.���s Botox, the $1.4 billion drug known for smoothing facial wrinkles, will derive a...

Allergan beats first-quarter forecastsmore

Allergan Inc (AGN.N) reported higher-than-expected first-quarter results on Wednesday, fueled by strong sales growth of...

European Stocks Drop as Holcim, Alstom Miss Profit Estimatesmore

addition to more than 25 companies reporting results across western Europe today, Time Warner Inc., Kellogg Co.

Allergan in eye drug deal that could top $420Mmore

IRVINE, Calif. - Allergan Inc. said Wednesday it will license a potential eye-disorder drug from Molecular Partners AG...

UPDATE 3-Allergan beats first-quarter forecastsmore

pct (Adds CEO comments, deal for retinal drug, byline) By Ransdell Pierson NEW YORK, May 4 (Reuters) - Allergan Inc...

AMAG tumbles in drug-sector tradingmore

2010. On Wednesday, analysts at J.P. Morgan downgraded AMAG���s stock to neutral from overweight. Shares of Allergan...

Stocks, Commodities Fall on China Concern; Silver Futures Slumpmore

yesterday, compared with a 0.3 percent decline on the S&P 500. Time Warner Inc., Kellogg Co. and Allergan Inc.

UPDATE 1-Allergan licenses drug for retinal diseasesmore

Allergan Inc (AGN.N) said on Wednesday it will pay up to $420 million to privately held Molecular Partners AG to...

Allergan and Molecular Partners Enter into an Exclusive License Agreem...more

(BUSINESS WIRE) -- Allergan, Inc. /quotes/comstock/13*!agn/quotes/nls/agn AGN +2.56% and Molecular Partners AG today...

Asia Stocks, Commodities Fall on China Concern; Dollar Climbsmore

yesterday, compared with a 0.3 percent decline on the S&P 500. Time Warner Inc., Kellogg Co. and Allergan Inc.

Allergan reports lower profitmore

By , MarketWatch BOSTON (MarketWatch) -- Botox-maker Allergan Inc. reported a lower first-quarter profit early...

UPDATE 1-Allergan beats first-quarter forecastsmore

Allergan Inc (AGN.N) reported on Wednesday better-than-expected first quarter results, fueled by strong sales growth of...

Morning MarketBeat: First Taste of April Jobs, More Earningsmore

InBev Offsets Volume Weakness With Strong Pricing Chipotle Hiring Probe Expands Court Slams Carlos Slim Key Earnings...

Allergan reports lower quarterly profitmore

BOSTON (MarketWatch) -- Allergan Inc. (NYSE:AGN

Maven Semantic: Movement Disorders Research Databasemore

in the Movement Disorders research field. Sample companies in database include: ACADIA Pharmaceuticals, Inc Advanced...

Cypress Pharmaceutical Announces Launch of Generic ELESTAT(R)more

of marketing exclusivity. ELESTAT(R) is a registered trademark of Boehringer Ingelheim International GmbH and is...

Allergan ordered to pay $212 million in Botox brain-injury lawsuitmore

suit filed by a Virginia man who claimed that use of the drug left him severely disabled. Botox-maker Allergan Inc.

Allergan Loses $212 Million Federal Botox Lawsuit in Virginiamore

April 28 (Bloomberg) -- Allergan Inc. was ordered by a Virginia jury to pay $212 million to a 67-year-old man who said...

Jury orders Allergan to pay $212 million in Botox casemore

A Virginia District Court jury has ordered Allergan Inc to pay $212 million to a man who claimed that injections of...

Jury orders Allergan to pay $212 mln in Botox casemore

A Virginia U.S. District Court jury has ordered Allergan Inc (AGN.N) to pay $212 million to a man who claimed that...

Va jury returns $212M verdict against Botox makermore

a Fredericksburg man who claims the drug Botox left him brain-damaged and disabled.The verdict against drug maker...

Hospira sets new CEO's course: Boost overseas salesmore

the role of new CEO F. Michael Ball, who joined the company in March from Irvine, Calif.-based Allergan Inc.

Lip plumper data may be dubious, FDA staff saysmore

drugs. The company's other big aesthetic product, Dysport, is partnered with French drugmaker Ipsen and competes with...

Breast Implant Removal Stops Device-Linked Cancer, Study Saysmore

shadow from these implants,��� Mattke, who heads Rand���s health consulting practice, said yesterday in a telephone...

Insiders Trading CODI, SFD, SNTA, IOSPmore

BO 19,000 $155,459 Tandy Leather Factory Inc (TLF) Bandera Partners Llc BO 23,123 $106,366 Allergan Inc (AGN) Herbert...

Top Sources: Allergan Inc.

  • grinza.com
  • Reuters
  • MarketWatch
  • TheDeal.com
  • ocbj.com
  • Wall Street Journal Online
  • BusinessWeek
  • Los Angeles Times
  • Morningstar.com
  • CNN Money

Most Active Users in this Topic

see all contributors in Allergan Inc.

Featured White Papers

Post a Job

Jobs in this Topic

Principal Clinical Data Integration Programmer Allergan | Bridgewater, NJ
Posted: Jun 15
Business Development Manager - BOTOX Cosmetic - Evanston Allergan | Chicago, IL
Posted: Jun 10
Principal Statistical Programmer Allergan | Santa Barbara, CA
Posted: Jun 12
Product Manager/Sr. Product Manager, Plastic Surgery Allergan | Irvine, CA
Posted: Jun 17
Principal Statistical Programmer - Systems Development Allergan | Irvine, CA
Posted: Jun 12

Report comment contains invalid characters. ()
cancel
Search Cancel